Stay updated on Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Sign up to get notified when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating a minor site version update.
    Difference
    0.0%
    Check dated 2026-07-07T00:45:48.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows a new revision version (v3.6.2) indicating a backend/content update without changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-29T17:51:47.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    No changes were detected. The page content and structure appear unchanged.
    Difference
    0.0%
    Check dated 2026-06-22T12:31:17.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a revision update (v3.6.0) and a formatting tweak to the Intervention/Treatment label.
    Difference
    0.4%
    Check dated 2026-06-15T08:49:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, indicating a newer version of the page content has been published. No additional changes are described in the provided data.
    Difference
    0.0%
    Check dated 2026-06-08T05:40:23.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, reflecting a refreshed build of the page content.
    Difference
    0.0%
    Check dated 2026-05-18T03:24:44.000Z thumbnail image

Stay in the know with updates to Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-2029 in Solid Tumors and DLBCL Clinical Trial page.